EVECXIA THERAPEUTICS
Evecxia Therapeutics is a privately funded, clinical-stage pharmaceutical company that is dedicated to realizing the therapeutic potential of 5-hydroxytryptophan. It aims to develop and commercialize EVX-101, to treat patients suffering from disabling, common, and costly neuropsychiatric conditions in which current therapies are inadequate, in particular depression. The company was established in 2013 and is based in Raleigh, North Carolina.
EVECXIA THERAPEUTICS
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.evecxia.com
Total Employee:
11+
Status:
Active
Total Funding:
15.12 M USD
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Advisors List
Board_member
Board_member
2020-01-01
Board_member
Current Employees Featured
Jacob Jacobsen Founder, Chief Scientific Officer @ Evecxia Therapeutics
Founder, Chief Scientific Officer
Marc Caron Co-founder @ Evecxia Therapeutics
Co-founder
Bret Berner Chief Technology Officer @ Evecxia Therapeutics
Chief Technology Officer
John Kaiser Chief Executive Officer @ Evecxia Therapeutics
Chief Executive Officer
2018-03-01
Joel Raskin Chief Medical Officer @ Evecxia Therapeutics
Chief Medical Officer
Founder
Official Site Inspections
http://www.evecxia.com
- Host name: ec2-18-222-195-17.us-east-2.compute.amazonaws.com
- IP address: 18.222.195.17
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
